Ingemar Qvarfordt
Overview
Explore the profile of Ingemar Qvarfordt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andersson R, Lingaas E, Qvarfordt I, Tammelin A
Eur J Anaesthesiol
. 2025 Jan;
42(3):278-279.
PMID: 39789924
No abstract available.
2.
Paulsson M, Cardenas E, Che K, Brundin B, Smith M, Qvarfordt I, et al.
Front Immunol
. 2023 May;
14:1178135.
PMID: 37234157
Background: Bacterial infection causes accumulation of neutrophils that release antimicrobial proteins including heparin-binding protein (HBP). In human airways, this neutrophil accumulation can be re-capitulated via intrabronchial exposure to lipopolysaccharide (LPS),...
3.
Hess-Wargbaner M, Jacobsson G, Bjork D, Edholm A, Qvarfordt I, Sundvall P, et al.
Lakartidningen
. 2022 Oct;
119.
PMID: 36255276
Optimizing antibiotic use to control the spread of antimicrobial resistance is a global health priority. The Swedish strategic programme against antibiotic resistance (Strama) has for many years supported the rational...
4.
Pournaras N, Andersson A, Kovach M, Padra M, Che K, Brundin B, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 May;
17:1179-1194.
PMID: 35620349
Purpose: Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are common comorbidities in chronic obstructive pulmonary disease (COPD), but the underlying pathogenic mechanisms are poorly understood. Given that these...
5.
Padra M, Benktander J, Padra J, Andersson A, Brundin B, Tengvall S, et al.
Am J Respir Cell Mol Biol
. 2021 Jun;
65(6):593-602.
PMID: 34192508
Chronic obstructive pulmonary disease (COPD) is associated with colonization by bacterial pathogens and repeated airway infections, leading to exacerbations and impaired lung function. The highly glycosylated mucins in the mucus...
6.
Paulsson M, Thelaus L, Riesbeck K, Qvarfordt I, Smith M, Linden A, et al.
Respir Res
. 2021 Jun;
22(1):174.
PMID: 34103069
Objectives: Ventilator-associated pneumonia (VAP) is difficult to diagnose using clinical criteria and no biomarkers have yet been proved to be sufficiently accurate. The use of the neutrophil-derived Heparin-binding protein (HBP)...
7.
Kovach M, Che K, Brundin B, Andersson A, Asgeirsdottir H, Padra M, et al.
Am J Respir Cell Mol Biol
. 2020 Oct;
64(2):173-182.
PMID: 33105081
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease with high morbidity and mortality. The IL-36 family are proinflammatory cytokines that are known to shape innate immune responses,...
8.
Stockfelt M, Christenson K, Andersson A, Bjorkman L, Padra M, Brundin B, et al.
J Innate Immun
. 2020 Aug;
12(6):480-489.
PMID: 32829330
There is incomplete mechanistic understanding of the mobilization of neutrophils in the systemic and local compartment in smokers with chronic obstructive pulmonary disease (COPD). In this pilot study, we characterized...
9.
Toren K, Blanc P, Qvarfordt I, Aspevall O, Schioler L
Ann Am Thorac Soc
. 2020 Jul;
17(12):1570-1575.
PMID: 32649216
The use of inhaled corticosteroids (ICS) is associated with increased pneumonia risk, but the risk of invasive pneumococcal disease (IPD) associated with ICS is not characterized. The aim was to...
10.
Padra M, Andersson A, Levanen B, Premaratne P, Asgeirsdottir H, Tengvall S, et al.
Clin Sci (Lond)
. 2020 May;
134(10):1107-1125.
PMID: 32400877
There is little information on mucins versus potential regulatory factors in the peripheral airway lumen of long-term smokers with (LTS+) and without (LTS-) chronic obstructive pulmonary disease (COPD). We explored...